Changes in cardiopulmonary reserve and peripheral arterial function concomitantly with subclinical inflammation and oxidative stress in patients with heart failure with preserved ejection fraction

International Journal of Vascular Medicine

Volumn 2014, Issue , 2014, Pages

  Vitiello, Damien ^a,b   Harel, François ^a,b   Touyz, Rhian M ^c,d   Sirois, Martin G ^a,b   Lavoie, Joel ^a   Myers, Jonathan ^e   Ducharme, Anique ^a   Racine, Normand ^a   O'Meara, Eileen ^a   Gayda, Mathieu ^a,b   Chabot Blanchet, Malorie ^a   Rouleau, Jean Lucien ^a   De Denus, Simon ^a,b   White, Michel ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERLEUKIN 6; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

AEROBIC CAPACITY; AGED; ARTERY BLOOD FLOW; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EXERCISE; FEMALE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RATE; HUMAN; INFLAMMATION; MALE; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; VENOUS BLOOD;

EID: 84897851118     PISSN: 20902824     EISSN: 20902832     Source Type: Journal    
DOI: 10.1155/2014/917271     Document Type: Article

References (32)

1. Puntawangkoon C., Kitzman D. W., Kritchevsky S. B., Hamilton C. A., Nicklas B., Leng X., Brubaker P. H., Hundley W. G., Reduced peripheral arterial blood flow with preserved cardiac output during submaximal bicycle exercise in elderly heart failure. Journal of Cardiovascular Magnetic Resonance 2009 11 1 48 2-s2.0-74049117080 10.1186/1532-429X-11-48
2. Bhella P. S., Prasad A., Heinicke K., Hastings J. L., Arbab-Zadeh A., Adams-Huet B., Pacini E. L., Shibata S., Palmer M. D., Newcomer B. R., Levine B. D., Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction. European Journal of Heart Failure 2011 13 12 1296 1304 2-s2.0-81855206158 10.1093/eurjhf/hfr133
3. Hollenberg M., Tager I. B., Oxygen uptake efficiency slope: an index of exercise performance and cardiopulmonary reserve requiring only submaximal exercise. Journal of the American College of Cardiology 2000 36 1 194 201 2-s2.0-0033926548 10.1016/S0735-1097(00)00691-4 (Pubitemid 30466133)
4. Van Laethem C., Bartunek J., Goethals M., Nellens P., Andries E., Vanderheyden M., Oxygen uptake efficiency slope, a new submaximal parameter in evaluating exercise capacity in chronic heart failure patients. American Heart Journal 2005 149 1 175 180 2-s2.0-12344333507 10.1016/j.ahj.2004.07.004 (Pubitemid 40126506)
5. Davies L. C., Wensel R., Georgiadou P., Cicoira M., Coats A. J. S., Piepoli M. F., Francis D. P., Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope. European Heart Journal 2006 27 6 684 690 2-s2.0-33644889404 10.1093/eurheartj/ehi672
6. Arena R., Brubaker P., Moore B., Kitzman D., The oxygen uptake efficiency slope is reduced in older patients with heart failure and a normal ejection fraction. International Journal of Cardiology 2010 144 1 101 102 2-s2.0-77954757793 10.1016/j.ijcard.2008.12.143
7. de Denus S., Lavoie J., Ducharme A., O'Meara E., Racine N., Sirois M. G., Neagoe P., Zhu L., Rouleau J., White M., Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction. Canadian Journal of Cardiology 2012 28 1 62 68 2-s2.0-84856028941 10.1016/j.cjca.2011.09.007
8. Niethammer M., Sieber M., von Haehling S., Anker S. D., Munzel T., Horstick G., Genth-Zotz S., Inflammatory pathways in patients with heart failure and preserved ejection fraction. International Journal of Cardiology 2008 129 1 111 117 2-s2.0-49349117049 10.1016/j.ijcard.2007.05.061
9. Clark A., Volterrani M., Swan J. W., Hue D., Hooper J., Coats A. J. S., Leg blood flow, metabolism and exercise capacity in chronic stable heart failure. International Journal of Cardiology 1996 55 2 127 135 2-s2.0-0030602913 10.1016/S0167-5273(96)02627-7 (Pubitemid 26246908)
10. Haykowsky M. J., Herrington D. M., Brubaker P. H., Morgan T. M., Hundley W. G., Kitzman D. W., Relationship of flow-mediated arterial dilation and exercise capacity in older patients with heart failure and preserved ejection fraction. Journals of Gerontology A 2013 68 2 161 167 10.1093/gerona/gls099
11. Hundley W. G., Bayram E., Hamilton C. A., Hamilton E. A., Morgan T. M., Darty S. N., Stewart K. P., Link K. M., Herrington D. M., Kitzman D. W., Leg flow-mediated arterial dilation in elderly patients with heart failure and normal left ventricular ejection fraction. American Journal of Physiology 2007 292 3 H1427 H1434 2-s2.0-33847726656 10.1152/ajpheart.00567.2006 (Pubitemid 46377130)
12. Meyer B., Mörtl D., Strecker K., Hülsmann M., Kulemann V., Neunteufl T., Pacher R., Berger R., Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptide. Journal of the American College of Cardiology 2005 46 6 1011 1018 2-s2.0-24944461146 10.1016/j.jacc.2005.04.060 (Pubitemid 41316508)
13. Myers J., Walsh D., Buchanan N., McAuley P., Bowes E., Froelicher V., Increase in blood lactate during ramp exercise: comparison of continuous and threshold models. Medicine and Science in Sports and Exercise 1994 26 11 1413 1419 2-s2.0-0027987125 (Pubitemid 24338239)
14. Normandin E., Nigam A., Meyer P., Acute responses to intermittent and continuous exercise in heart failure patients. Canadian Journal of Cardiology 2013 29 4 466 471 10.1016/j.cjca.2012.07.001
15. Baba R., Nagashima M., Goto M., Nagano Y., Yokota M., Tauchi N., Nishibata K., Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. Journal of the American College of Cardiology 1996 28 6 1567 1572 2-s2.0-0030588919 10.1016/S0735-1097(96)00412-3 (Pubitemid 26391865)
16. Virdis A., Neves M. F., Amiri F., Viel E., Touyz R. M., Schiffrin E. L., Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension 2002 40 4 504 510 2-s2.0-0036791717 10.1161/01.HYP. 0000034738.79310.06
17. Harel F., Olamaei N., Ngo Q., Dupuis J., Khairy P., Arterial flow measurements during reactive hyperemia using NIRS. Physiological Measurement 2008 29 9 1033 1040 2-s2.0-51849090014 10.1088/0967-3334/29/9/003
18. Borlaug B. A., Melenovsky V., Russell S. D., Kessler K., Pacak K., Becker L. C., Kass D. A., Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 2006 114 20 2138 2147 2-s2.0-33750995868 10.1161/CIRCULATIONAHA.106.632745 (Pubitemid 44747894)
19. Phan T. T., Abozguia K., Nallur Shivu G., Mahadevan G., Ahmed I., Williams L., Dwivedi G., Patel K., Steendijk P., Ashrafian H., Henning A., Frenneaux M., Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. Journal of the American College of Cardiology 2009 54 5 402 409 2-s2.0-67650547206 10.1016/j.jacc.2009.05.012
20. Phan T. T., Shivu G. N., Abozguia K., Davies C., Nassimizadeh M., Jimenez D., Weaver R., Ahmed I., Frenneaux M., Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction. Circulation 2010 3 1 29 34 2-s2.0-76549104730 10.1161/ CIRCHEARTFAILURE.109.877720
21. Bishu K., Deswal A., Chen H. H., Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction. American Heart Journal 2012 164 5 763 770 10.1016/j.ahj.2012.08.014
22. Kalogeropoulos A., Georgiopoulou V., Psaty B. M., Rodondi N., Smith A. L., Harrison D. G., Liu Y., Hoffmann U., Bauer D. C., Newman A. B., Kritchevsky S. B., Harris T. B., Butler J., Inflammatory markers and incident heart failure risk in older adults. The health ABC (health, aging, and body composition) study. Journal of the American College of Cardiology 2010 55 19 2129 2137 2-s2.0-77951639762 10.1016/j.jacc.2009.12.045
23. Borlaug B. A., Olson T. P., Lam C. S. P., Flood K. S., Lerman A., Johnson B. D., Redfield M. M., Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. Journal of the American College of Cardiology 2010 56 11 845 854 2-s2.0-77956330748 10.1016/j.jacc.2010.03.077
24. Tschöpe C., Kašner M., Westermann D., Gaub R., Poller W. C., Schultheiss H., The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. European Heart Journal 2005 26 21 2277 2284 2-s2.0-27544455785 10.1093/eurheartj/ehi406 (Pubitemid 41541392)
25. Mohammed S. F., Ohtani T., Korinek J., Lam C. S. P., Larsen K., Simari R. D., Valencik M. L., Burnett J. C., Redfield M. M., Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via 'nongenomic effects'. Circulation 2010 122 4 370 378 2-s2.0-77955172275 10.1161/CIRCULATIONAHA.109.915215
26. Braunwald E., Medical progress: biomarkers in heart failure. New England Journal of Medicine 2008 358 20 2094 2159 2-s2.0-43549099569 10.1056/NEJMra0800239 (Pubitemid 351679601)
27. Nagaset H., Woessner J. F. Jr., Matrix metalloproteinases. Journal of Biological Chemistry 1999 274 31 21491 21494 2-s2.0-0033618337 10.1074/jbc.274.31.21491 (Pubitemid 29359963)
28. Cox M., Hawkins U. A., Hoit B. D., Tyagi S. C., Attenuation of oxidative stress and remodeling by cardiac inhibitor of metalloproteinase protein transfer. Circulation 2004 109 17 2123 2128 2-s2.0-2442503738 10.1161/01.CIR.0000127429.53391.78 (Pubitemid 38620222)
29. Gage J. R., Fonarow G., Hamilton M., Widawski M., Martínez-Maza O., Vredevoe D. L., Beta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure. NeuroImmunoModulation 2004 11 3 173 180 2-s2.0-1842611509 10.1159/000076766 (Pubitemid 38453113)
30. Zhang Y., Popović Z. B., Bibevski S., Fakhry I., Sica D. A., Van Wagoner D. R., Mazgalev T. N., Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circulation 2009 2 6 692 699 2-s2.0-77953660179 10.1161/CIRCHEARTFAILURE.109.873968
31. Preumont N., Unger P., Goldman S., Berkenboom G., Effect of long-term angiotensin II type I receptor antagonism on peripheral and coronary vasomotion. Cardiovascular Drugs and Therapy 2004 18 3 197 202 2-s2.0-3142750486 10.1023/B:CARD.0000033640.17844.4b (Pubitemid 38918954)
32. Warnholtz A., Ostad M. A., Heitzer T., Thuneke F., Fröhlich M., Tschentscher P., Schwedhelm E., Böger R., Meinertz T., Munzel T., AT1-receptor blockade with irbesartan improves peripheral but not coronary endothelial dysfunction in patients with stable coronary artery disease. Atherosclerosis 2007 194 2 439 445 2-s2.0-34848814719 10.1016/j.atherosclerosis. 2006.08.034 (Pubitemid 47513075)